Status: Not yet recruiting
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
A phase 2a, multicenter, randomized, double-blind, placebo-controlled study of TH104 in primary biliary cholangitis (PBC) participants with moderate to severe pruritus.
Participants needed: 40
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Tharimmune IncUpdated: Sep 9, 2025
Eligibility criteria
Men or women aged 18 to 75 years, inclusive, at the time of signing the informed... [+11]
Screening total bilirubin >2.0 x ULN. [+16]